A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD

Clinical trial NCT07086313 · RECRUITING

Trial details

NCT number: NCT07086313
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention-Deficit Hyperactivity Disorder(ADHD)

Start date: 2025-09-03
Primary completion: 2027-08-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.